Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence on opioid tolerance development

2021/43/B/NZ7/00230

Keywords:

neuropathic pain chemokines neuroimmunology microglia astroglia opioid analgesic drugs

Descriptors:

  • NZ7_014:

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Instytut Farmakologii PAN

woj. małopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Joanna Gabriela Mika 

Number of co-investigators in the project: 6

Call: OPUS 22 - announced on 2021-09-15

Amount awarded: 1 923 624 PLN

Project start date (Y-m-d): 2022-07-15

Project end date (Y-m-d): 2026-07-14

Project duration:: 48 months (the same as in the proposal)

Project status: Pending project

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (13)
  1. Phenytoin decreases pain-like behaviors and improves opioid analgesia in a rat model of neuropathic pain
    Authors:
    Kocot-Kępska M, Pawlik K, Ciapała K, Makuch W, Zajączkowska R, Dobrogowski J, Przeklasa-Muszyńska A, Mika J.
    Academic press:
    Brain Sci. (rok: 2023, tom: 13, strony: 46038), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/brainsci13060858 - link to the publication
  2. CC Chemokine Family Members' Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury-A Review of Clinical and Experimental Findings
    Authors:
    Ciechanowska A, Mika J.
    Academic press:
    Int J Mol Sci. (rok: 2024, tom: 25, strony: 15707), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms25073788 - link to the publication
  3. Pharmacological modulation of the MIP-1 family and their receptors reduces neuropathic pain symptoms and influences morphine analgesia: evidence from a mouse model
    Authors:
    Ciechanowska A, Pawlik K, Ciapała K, Mika J.
    Academic press:
    Brain Sci. (rok: 2023, tom: 13, strony: 46046), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/brainsci13040579 - link to the publication
  4. Analgesic effects of fisetin, peimine, astaxanthin, artemisinin, bardoxolone methyl and 740 Y-P and their influence on opioid analgesia in a mouse model of neuropathic pain
    Authors:
    Ciapała K, Rojewska E, Pawlik K, Ciechanowska A, Mika J
    Academic press:
    Int J. Mol Sci. (rok: 2023, tom: 24, strony: 46042), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms24109000 - link to the publication
  5. Pharmacological evidence of the important roles of CCR1 and CCR3 and their endogenous ligands CCL2/7/8 in hypersensitivity based on a murine model of neuropathic pain
    Authors:
    Pawlik K, Ciapała K, Ciechanowska A, Kwiatkowski K, Mika J.
    Academic press:
    Cells (rok: 2023, tom: 12, strony: 46050), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/cells12010098 - link to the publication
  6. A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model
    Authors:
    Bober A, Piotrowska A, Pawlik K, Ciapała K, Maciuszek M, Makuch W, Mika J.
    Academic press:
    Int J Mol Sci. (rok: 2024, tom: 25, strony: 46044), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms25137410 - link to the publication
  7. A Missing Puzzle in Preclinical Studies-Are CCR2, CCR5, and Their Ligands' Roles Similar in Obesity-Induced Hypersensitivity and Diabetic Neuropathy?-Evidence from Rodent Models and Clinical Studies
    Authors:
    Bober A, Mika J, Piotrowska A.
    Academic press:
    Int J Mol Sci. (rok: 2024, tom: 25, strony: 46039), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms252011323 - link to the publication
  8. Targeting members of the chemokine family as a novel approach to treating neuropathic pain.
    Authors:
    Pawlik K, Mika J
    Academic press:
    Molecules (rok: 2023, tom: 28, strony: 15707), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/molecules28155766 - link to the publication
  9. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies
    Authors:
    Ciechanowska A, Rojewska E, Piotrowska A, Barut J, Pawlik K, Ciapała K, Kreiner G, Mika J.
    Academic press:
    Front Immunol. (rok: 2022, tom: 13, strony: 46043), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2022.1058204 - link to the publication
  10. Mirogabalin decreases pain-like behaviors by inhibiting the microglial/macrophage activation, p38MAPK signaling, and pronociceptive CCL2 and CCL5 release in a mouse model of neuropathic pain
    Authors:
    Zajączkowska R, Pawlik K, Ciapała K, Piotrowska A, Ciechanowska A, Rojewska E, Kocot-Kępska M, Makuch W, Wordliczek J, Mika J
    Academic press:
    Pharmaceuticals (rok: 2023, tom: 16, strony: 46035), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ph16071023 - link to the publication
  11. CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy.
    Authors:
    Bogacka J, Pawlik K, Ciapała K, Ciechanowska A, Mika J.
    Academic press:
    Int J Mol Sci (rok: 2022, tom: 23, strony: 46042), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms232415638 - link to the publication
  12. Advances in neuropathic pain research: selected intracellular factors as potential targets for multidirectional analgesics.
    Authors:
    Ciapała K, Mika J.
    Academic press:
    Pharmaceuticals (rok: 2023, tom: 16, strony: 46046), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ph16111624 - link to the publication
  13. Astaxanthin has a beneficial influence on pain-related symptoms and opioid-induced hyperalgesia in mice with diabetic neuropathy-evidence from behavioral studies
    Authors:
    Ciapała K, Pawlik K, Ciechanowska A, Makuch W, Mika J.
    Academic press:
    Pharmacol Rep. (rok: 2024, tom: 76, strony: 1346-1362), Wydawca: Springer
    Status:
    Published
    DOI:
    10.1007/s43440-024-00671-9 - link to the publication